Display Settings:

Format

Send to:

Choose Destination
    Am J Hum Genet. 2007 Dec;81(6):1289-97. Epub 2007 Oct 16.

    Contribution of SHANK3 mutations to autism spectrum disorder.

    Source

    The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, M5G 1L7, Canada.

    Abstract

    Mutations in SHANK3, which encodes a synaptic scaffolding protein, have been described in subjects with an autism spectrum disorder (ASD). To assess the quantitative contribution of SHANK3 to the pathogenesis of autism, we determined the frequency of DNA sequence and copy-number variants in this gene in 400 ASD-affected subjects ascertained in Canada. One de novo mutation and two gene deletions were discovered, indicating a contribution of 0.75% in this cohort. One additional SHANK3 deletion was characterized in two ASD-affected siblings from another collection, which brings the total number of published mutations in unrelated ASD-affected families to seven. The combined data provide support that haploinsufficiency of SHANK3 can cause a monogenic form of autism in sufficient frequency to warrant consideration in clinical diagnostic testing.

    PMID:
    17999366
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2276348
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Figure  1. 
    Figure  3. 
    Figure  2. 

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk